Clinical Trials Browser

Phase 2 × Not yet recruiting × avapritinib × Clear all

NCT06765915 2025-01-09

Avapritinib Maintenance for AML With KIT Mutations

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute